FRESENIUS MEDICAL CARE AG (FME.DE) Stock Price & Overview

FRA:FMEDE0005785802

Current stock price

37.47 EUR
-0.27 (-0.72%)
Last:

The current stock price of FME.DE is 37.47 EUR. Today FME.DE is down by -0.72%. In the past month the price decreased by -8.33%. In the past year, price decreased by -16.13%.

FME.DE Key Statistics

52-Week Range35.67 - 54.02
Current FME.DE stock price positioned within its 52-week range.
1-Month Range37.23 - 41.64
Current FME.DE stock price positioned within its 1-month range.
Market Cap
20.93B
P/E
8.73
Fwd P/E
9.34
EPS (TTM)
4.29
Dividend Yield
3.76%

FME.DE Stock Performance

Today
-0.72%
1 Week
-5.13%
1 Month
-8.33%
3 Months
-6.45%
Longer-term
6 Months -12.76%
1 Year -16.13%
2 Years +5.86%
3 Years -3.48%
5 Years -39.83%
10 Years -51.52%

FME.DE Stock Chart

FRESENIUS MEDICAL CARE AG / FME Daily stock chart

FME.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to FME.DE. When comparing the yearly performance of all stocks, FME.DE is a bad performer in the overall market: 83.04% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

FME.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to FME.DE. FME.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FME.DE Earnings

On February 24, 2026 FME.DE reported an EPS of 1.44 and a revenue of 5.07B. The company beat EPS expectations (35.55% surprise) and beat revenue expectations (3.58% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported€1.44
Revenue Reported5.07B
EPS Surprise 35.55%
Revenue Surprise 3.58%

FME.DE Forecast & Estimates

27 analysts have analysed FME.DE and the average price target is 45.79 EUR. This implies a price increase of 22.2% is expected in the next year compared to the current price of 37.47.

For the next year, analysts expect an EPS growth of -6.53% and a revenue growth 0.74% for FME.DE


Analysts
Analysts65.93
Price Target45.79 (22.2%)
EPS Next Y-6.53%
Revenue Next Year0.74%

FME.DE Groups

Sector & Classification

FME.DE Financial Highlights

Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 4.29. The EPS increased by 32% compared to the year before.


Income Statements
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Industry RankSector Rank
PM (TTM) 4.98%
ROA 3.16%
ROE 7.35%
Debt/Equity 0.65
Chartmill High Growth Momentum
EPS Q2Q%58.24%
Sales Q2Q%-0.29%
EPS 1Y (TTM)32%
Revenue 1Y (TTM)1.51%

FME.DE Ownership

Ownership
Inst Owners44.27%
Shares558.58M
Float372.18M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About FME.DE

Company Profile

FME logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Company Info

IPO: 1996-10-02

FRESENIUS MEDICAL CARE AG

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN DE

Employees: 111513

FME Company Website

FME Investor Relations

Phone: 4961726090

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What does FME do?

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.


What is the current price of FME stock?

The current stock price of FME.DE is 37.47 EUR. The price decreased by -0.72% in the last trading session.


What is the dividend status of FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 3.76%. The yearly dividend amount is currently 1.48.


What is the ChartMill rating of FRESENIUS MEDICAL CARE AG stock?

FME.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the GICS sector and industry of FME stock?

FRESENIUS MEDICAL CARE AG (FME.DE) operates in the Health Care sector and the Health Care Providers & Services industry.


When does FRESENIUS MEDICAL CARE AG (FME.DE) report earnings?

FRESENIUS MEDICAL CARE AG (FME.DE) will report earnings on 2026-05-05.